-
ICT Ep17: Exploring Enrollment Gaps in Oncology Trials with Selin Kurnaz (Part 2 of 3)
- 2024/10/09
- 再生時間: 17 分
- ポッドキャスト
-
サマリー
あらすじ・解説
In this episode of Innovating Clinical Trials, hosts Liam Eves and Ted Trafford continue their discussion with Selin Kurnaz, CEO and founder of Massive Bio, an AI-powered platform that connects cancer patients with clinical trials. The conversation centers around the critical challenges in oncology trial enrollment, from recruitment failures to the operational difficulties encountered in the "Last Mile." We discuss the need for transparency, education, and a rethinking of traditional clinical trial processes. Selin discusses the complexity of site selection, prescreening, and patient identification, highlighting that the current system often overlooks the operational steps that are crucial for successful trial participation.